125 related articles for article (PubMed ID: 22356654)
21. Pathological aggressiveness of prostatic carcinomas related to RNASEL R462Q allelic variants.
Larson BT; Magi-Galluzzi C; Casey G; Plummer SJ; Silverman R; Klein EA
J Urol; 2008 Apr; 179(4):1344-8. PubMed ID: 18289577
[TBL] [Abstract][Full Text] [Related]
22. Association between miRNA-146a rs2910164 (G/C) polymorphism with the susceptibility to chronic HBV infection and spontaneous viral clearance in an Iranian population.
Khanizadeh S; Hasanvand B; Nikoo HR; Anbari K; Adhikary H; Shirkhani S; Lashgarian HE
J Med Virol; 2019 Jun; 91(6):1063-1068. PubMed ID: 30624803
[TBL] [Abstract][Full Text] [Related]
23. Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer.
Madsen BE; Ramos EM; Boulard M; Duda K; Overgaard J; Nordsmark M; Wiuf C; Hansen LL
PLoS One; 2008 Jun; 3(6):e2492. PubMed ID: 18575592
[TBL] [Abstract][Full Text] [Related]
24. MHC and the viral hepatitides.
Thursz M
QJM; 2001 Jun; 94(6):287-91. PubMed ID: 11391026
[No Abstract] [Full Text] [Related]
25. Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study.
Fesinmeyer MD; Kwon EM; Fu R; Ostrander EA; Stanford JL
Prostate; 2011 Oct; 71(14):1538-47. PubMed ID: 21360564
[TBL] [Abstract][Full Text] [Related]
26. RNASEL and RNASEL-inhibitor variation and prostate cancer risk in Afro-Caribbeans.
Shea PR; Ishwad CS; Bunker CH; Patrick AL; Kuller LH; Ferrell RE
Prostate; 2008 Mar; 68(4):354-9. PubMed ID: 18189233
[TBL] [Abstract][Full Text] [Related]
27. IL17A gene polymorphisms: relationship to predisposition for chronic viral hepatitis and progression to liver cirrhosis in kazakh population.
Massabayeva MR; Aukenov NE; Mussazhanova ZB; Saenko VA; Rogounovitch TI; Shaimardanov NK; Kurmanova BR; Barkibaeva NR; Rakhypbekov TK
Vopr Virusol; 2016; 61(5):212-9. PubMed ID: 29323853
[TBL] [Abstract][Full Text] [Related]
28. Serodiagnosis of infection with the AIDS virus and other human retroviruses.
Schochetman G; Epstein JS; Zuck TF
Annu Rev Microbiol; 1989; 43():629-59. PubMed ID: 2679365
[No Abstract] [Full Text] [Related]
29. Relationship between programmed cell death-1 polymorphisms and clearance of hepatitis B virus.
Ülger Y; Bayram S; Sandıkçı MÜ; Akgöllü E; Bekar A
Int J Immunogenet; 2015 Jun; 42(3):133-9. PubMed ID: 25736598
[TBL] [Abstract][Full Text] [Related]
30. Genetic variations of SOCS1 are associated with chronic hepatitis B virus infection.
Zhang P; Li F; Li N; Zhu Q; Yang C; Han Q; Chen J; Lv Y; Yu L; Wei P; Liu Z
Hum Immunol; 2014 Aug; 75(8):709-14. PubMed ID: 24768946
[TBL] [Abstract][Full Text] [Related]
31. Evidence of serological cross-reactivities with human immunodeficiency virus types 1 and 2 and human T-lymphotropic virus types I and II in sera of pregnant women in Ibadan, Nigeria.
Olaleye DO; Ekweozor CC; Sheng Z; Rasheed S
Int J Epidemiol; 1995 Feb; 24(1):198-203. PubMed ID: 7797344
[TBL] [Abstract][Full Text] [Related]
32. Serological and molecular screening for viruses in blood donors from Ntcheu, Malawi: high prevalence of HIV-1 subtype C and of markers of hepatitis B and C viruses.
Candotti D; Mundy C; Kadewele G; Nkhoma W; Bates I; Allain JP
J Med Virol; 2001 Sep; 65(1):1-5. PubMed ID: 11505436
[TBL] [Abstract][Full Text] [Related]
33. Association between chronic hepatitis B virus infection and HLA-DP gene polymorphisms in the Turkish population.
Akgöllü E; Bilgin R; Akkız H; Ülger Y; Kaya BY; Karaoğullarından Ü; Arslan YK
Virus Res; 2017 Mar; 232():6-12. PubMed ID: 28119119
[TBL] [Abstract][Full Text] [Related]
34. The Influence of B and T Lymphocyte Attenuator Genetic Variants on Susceptibility to Chronic Hepatitis B Virus Infection.
Tang J; Fei J; Gu C; Liu W; Li M; Zhou C
Cell Physiol Biochem; 2018; 45(6):2540-2547. PubMed ID: 29558758
[TBL] [Abstract][Full Text] [Related]
35. The reasons to include the serology of human T-lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in the clinical follow-up of patients with viral hepatitis B and C in Brazil.
Campos KR; Alves FA; Lemos MF; Moreira RC; Marcusso RMN; Caterino-de-Araujo A
PLoS Negl Trop Dis; 2020 May; 14(5):e0008245. PubMed ID: 32453768
[TBL] [Abstract][Full Text] [Related]
36. Effect of IL28B genotype on hepatitis B and C virus infection.
Stättermayer AF; Ferenci P
Curr Opin Virol; 2015 Oct; 14():50-5. PubMed ID: 26284971
[TBL] [Abstract][Full Text] [Related]
37. Changing rate of non-B subtypes and coinfection with hepatitis B/C viruses in newly diagnosed HIV type 1 individuals in Spain.
Treviño A; Soriano V; Rodríguez C; Arredondo M; Rivas P; Herrero-Mendoza D; Parra P; del Romero J; Anta L; Puente S; de Mendoza C
AIDS Res Hum Retroviruses; 2011 Jun; 27(6):633-8. PubMed ID: 21039316
[TBL] [Abstract][Full Text] [Related]
38. Positive selection on the gene RNASEL: correlation between patterns of evolution and function.
Jin W; Wu DD; Zhang X; Irwin DM; Zhang YP
Mol Biol Evol; 2012 Oct; 29(10):3161-8. PubMed ID: 22513284
[TBL] [Abstract][Full Text] [Related]
39. Interleukin IL-1B gene polymorphism in Tunisian patients with chronic hepatitis B infection: Association with replication levels.
Ben Dhifallah I; Ayouni K; Najjar G; Chelbi H; Sadraoui A; Hammami W; Touzi H; Triki H
Microbiol Immunol; 2020 Jul; 64(7):512-519. PubMed ID: 31944355
[TBL] [Abstract][Full Text] [Related]
40. Understanding the host genetics of chronic hepatitis B and C.
Thursz M; Yee L; Khakoo S
Semin Liver Dis; 2011 May; 31(2):115-27. PubMed ID: 21538279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
